OMI:NYE-Owens & Minor Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 12.72

Change

+0.16 (+1.27)%

Market Cap

N/A

Volume

0.20M

Analyst Target

USD 15.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

-0.10 (-0.04%)

USD 44.01B
CAH Cardinal Health Inc

+0.48 (+0.41%)

USD 28.62B
MCK McKesson Corporation

+2.37 (+0.41%)

N/A
NVG Nuveen AMT Free Municipal Cred..

+0.01 (+0.08%)

N/A

ETFs Containing OMI

DFVE DoubleLine ETF Trust 0.23 % 0.00 %

+0.20 (+0.71%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -33.99% 20% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -33.99% 20% F 6% D-
Trailing 12 Months  
Capital Gain -34.97% 20% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.97% 20% F 6% D-
Trailing 5 Years  
Capital Gain 150.89% 80% B- 92% A
Dividend Return 0.47% 20% F 1% F
Total Return 151.36% 60% D- 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 61.63% 100% F 95% A
Dividend Return 61.66% 100% F 95% A
Total Return 0.03% 20% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 167.42% 20% F 6% D-
Risk Adjusted Return 36.83% 40% F 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector